Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Cyclo Therapeutics Inc (CYTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2010	12-2009
Cash Flows From Operating Activities
Net Income	205	74	-98	-38	-193
Depreciation Amortization	244	143	33	21	21
Income taxes - deferred	80	25	N/A	25	N/A
Accounts receivable	-34	-19	39	-45	-13
Other Working Capital	-10	-200	141	23	36
Other Operating Activity	72	36	72	223	258
Operating Cash Flow	$557	$59	$186	$210	$108

Cash Flows From Investing Activities
PPE Investments	-155	-166	-554	-443	-43
Other Investing Activity	0	0	0	-7	7
Investing Cash Flow	$-155	$-166	$-554	$-449	$-37

Cash Flows From Financing Activities
Debt Issued	N/A	N/A	421	N/A	N/A
Debt Repayment	-134	-47	-23	-1	N/A
Common Stock Issued	N/A	50	N/A	8	N/A
Common Stock Repurchased	N/A	N/A	N/A	N/A	-9
Other Financing Activity	-22	0	-10	0	0
Financing Cash Flow	$-156	$3	$388	$7	$-9

Beginning Cash Position	23	127	107	339	277
End Cash Position	269	23	127	107	339
Net Cash Flow	$246	$-104	$20	$-232	$62

Free Cash Flow
Operating Cash Flow	557	59	186	210	108
Capital Expenditure	-157	-166	-554	-443	-43
Free Cash Flow	400	-108	-368	-233	65